Mega-ROX (@megaroxtrial) 's Twitter Profile
Mega-ROX

@megaroxtrial

The Mega Randomised Registry Trial Comparing Conservative vs. Liberal Oxygenation Targets (N=40,000) #MegaROX #LOGICALtrial

ID: 1501713403974275075

calendar_today10-03-2022 00:16:08

77 Tweet

411 Followers

101 Following

Paul Young (@dogicuma) 's Twitter Profile Photo

Thanks to those who recruited Mega-ROX participants in Australia, New Zealand, Kuwait, Nepal, & Pakistan while I was asleep last night. We have now recruited 8002 patients! Patient 8000 was enrolled by Abdulrahman Al-Fares in ๐Ÿ‡ฐ๐Ÿ‡ผ.

Paul Young (@dogicuma) 's Twitter Profile Photo

Here's how recruitment went while I was asleep last night: ๐Ÿ‡ฆ๐Ÿ‡บ 9983 ๐Ÿ‡ต๐Ÿ‡ฐ 9984 ๐Ÿ‡ณ๐Ÿ‡ฟ 9985 ๐Ÿ‡ฆ๐Ÿ‡บ 9986 ๐Ÿ‡ฆ๐Ÿ‡บ 9987 ๐Ÿ‡ณ๐Ÿ‡ฟ 9988 ๐Ÿ‡ฆ๐Ÿ‡บ 9989 ๐Ÿ‡ต๐Ÿ‡ฐ 9990 ๐Ÿ‡ต๐Ÿ‡ฐ 9991 ๐Ÿ‡ฆ๐Ÿ‡บ 9992 ๐Ÿ‡ฆ๐Ÿ‡บ 9993 Mega-ROX

Diptesh Aryal (@diptesharyal) 's Twitter Profile Photo

The Mega-ROX research team in Nepal recruited the 100th trial participant today. Contributing to evidence generation in critical care.A proud moment for all of us. Big round of applause to the Nepal team and the participants.Thanks to Paul Young MRINZ - Medical Research Institute of New Zealand CRITIcal CARE Asia

Mega-ROX (@megaroxtrial) 's Twitter Profile Photo

Thanks to the #anzicsctg for another fantastic research coordinator workshop today. Great presentations and lots of thought provoking discussions regarding consent, monitoring, and the wellbeing/future of the global nursing workforce. Always a privilege to be here #ircig #anzics

Thanks to the #anzicsctg for another fantastic research coordinator workshop today. Great presentations and lots of thought provoking discussions regarding consent, monitoring, and the wellbeing/future of the global nursing workforce. Always a privilege to be here #ircig #anzics
Paul Young (@dogicuma) 's Twitter Profile Photo

Welcome to 2024. The Mega-ROX starts the year with 19823 participants recruited from ๐Ÿ‡ง๐Ÿ‡ท ๐Ÿ‡จ๐Ÿ‡ฆ ๐Ÿ‡ฎ๐Ÿ‡น ๐Ÿ‡ฒ๐Ÿ‡พ ๐Ÿ‡ณ๐Ÿ‡ต ๐Ÿ‡ฎ๐Ÿ‡ณ ๐Ÿ‡ต๐Ÿ‡ฐ ๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡ฐ๐Ÿ‡ผ๐Ÿ‡ด๐Ÿ‡ฒ ๐Ÿ‡ฆ๐Ÿ‡บ๐Ÿ‡ณ๐Ÿ‡ฟ๐Ÿ‡ฎ๐Ÿ‡ช